Edition:
United States

Medtronic PLC (MDT)

MDT on New York Consolidated

78.34USD
20 Oct 2017
Change (% chg)

$-0.14 (-0.18%)
Prev Close
$78.48
Open
$78.77
Day's High
$78.88
Day's Low
$78.17
Volume
4,173,780
Avg. Vol
4,727,114
52-wk High
$89.72
52-wk Low
$69.35

Chart for

About

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group,... (more)

Overall

Beta: 1.00
Market Cap(Mil.): $106,118.70
Shares Outstanding(Mil.): 1,354.59
Dividend: 0.46
Yield (%): 2.35

Financials

  Industry Sector
P/E (TTM): -- 33.06 16.52
EPS (TTM): -- -- --
ROI: -- 13.87 11.32
ROE: -- 16.68 15.18

BRIEF-Medtronic care and American Well announce strategic partnership to integrate Telehealth capabilities

* Medtronic Care Management Services and American Well announce strategic partnership to integrate Telehealth capabilities Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Oct 16 2017

BRIEF-Medtronic to establish innovation center in Chengdu

* Medtronic-‍within five years of operation, projects an annual training capacity of approximately 7,000 healthcare professionals at Chengdu Center​ Source text for Eikon: Further company coverage:

Oct 10 2017

BRIEF-Medtronic Endurant II/IIs stent graft system receives FDA approval to treat short neck anatomies

* Medtronic Endurant II/IIs stent graft system receives FDA approval to treat short neck anatomies when used with Heli-FX EndoAnchor system

Oct 09 2017

BRIEF-Medtronic provides update on impact from hurricane Maria

* Medtronic Plc - ‍estimates an impact to both revenue and non-gaap net earnings up to $250 million dollars in fiscal 2018 Q2​

Oct 06 2017

BRIEF-Medtronic reaffirms guidance, provides update on hurricane Maria impact

* Says ‍excluding expected impact of hurricane Maria,‍ co reaffirms fiscal 2018 q2 and full fiscal year guidance provided on august 22, 2017​

Oct 06 2017

J&J's diabetes care unit to exit insulin pump business

Oct 5 Animas Corp, Johnson & Johnson's diabetes care unit, said it intends to exit the insulin pump business and has selected Medtronic Plc as its partner for patients on insulin pumps.

Oct 05 2017

BRIEF-J&J diabetes care company Animas to close operations and exit insulin pump market

* ‍Johnson & Johnson Diabetes Care Companies - Animas corp intends to discontinue manufacturing, sale of animas vibe and onetouch ping insulin pumps

Oct 05 2017

BRIEF-Medtronic receives U.S. FDA approval for its HeartWare HVAD System for destination therapy​

* Medtronic HeartWare(TM) HVAD(TM) system approved for destination therapy

Sep 27 2017

BRIEF-Medtronic announces clinical study to evaluate its Corevalve Evolut pro system in 'everyday' clinical practice

* Medtronic announces clinical study to evaluate the Corevalve Evolut pro system in 'everyday' clinical practice

Sep 21 2017

BRIEF-Medtronic announces FDA approval, U.S. launch of spinal cord stimulator

* Medtronic announces FDA approval and U.S. launch of next generation spinal cord stimulator for chronic pain management Source text for Eikon: Further company coverage:

Sep 18 2017

Earnings vs. Estimates